LAISHA
Open Laisha

ICAR AICE-JRF/SRF Veterinary and Animal Biotechnology: practice questions

ICAR AICE-JRF/SRF (PhD) · India · NTA for ICAR

Original practice questions written to the published syllabus · not past papers
10worked here, free
41written to this exam in this subject
12syllabus units

What this subject covers

Molecular tools used in diagnosis, vaccines and reproduction: recombinant DNA, PCR, cell culture, monoclonal antibodies, cloning, transgenics and genomics, with their biosafety rules.

In the exams: ICAR AICE-JRF core group 08; ICAR AIEEA-PG 12 (Animal Biotechnology)

What ICAR AICE-JRF/SRF asks from it

ICAR AICE-JRF/SRF (PhD), core group 08

Deeper mechanism and calculation: delta-delta-Ct fold change, standard curves and copy numbers, epigenetic reprogramming in cloning, NHEJ versus HDR, genomic selection accuracy and genetic gain, GBLUP and single-step evaluation, and validation of molecular diagnostics.

Where the 41 questions fall

How our questions for ICAR AICE-JRF/SRF spread across the units of Veterinary and Animal Biotechnology. Difficulty: 0 easy, 16 medium, 25 hard.

PCR and quantitative PCR6
Genomics and bioinformatics6
Stem cells4
Embryo transfer and in-vitro fertilisation4
Molecular biology and recombinant DNA3
Molecular diagnostics3
Hybridoma technology and monoclonal antibodies3
Sub-unit and recombinant vaccines3
Transgenic animals3
Animal tissue culture2
Cloning2
Biosafety and regulation2

10 practice questions, worked

Choose an answer, then open the working. Each explanation says why the right answer is right and why the others are not.

1 · Molecular biology and recombinant DNA · medium

A student transforms 1 ng of plasmid into competent cells, adds recovery medium to a final volume of 1 mL, spreads 100 microlitres and counts 150 colonies. The transformation efficiency is:

  1. 1.5 x 10^9 transformants per microgram
  2. 1.5 x 10^5 transformants per microgram
  3. 1.5 x 10^3 transformants per microgram
  4. 1.5 x 10^6 transformants per microgram
Answer and working

D. 1.5 x 10^6 transformants per microgram

DNA plated = 1 ng x (100/1000) = 0.1 ng. Colonies per ng = 150/0.1 = 1500; per microgram = 1.5 x 10^6. Forgetting that only a tenth was plated gives 1.5 x 10^5; stopping at per-nanogram gives 1.5 x 10^3.

2 · PCR and quantitative PCR · medium

A qPCR standard curve of ten-fold dilutions has a slope of -3.6. The amplification efficiency is closest to:

  1. 78 percent
  2. 100 percent
  3. 110 percent
  4. 90 percent
Answer and working

D. 90 percent

E = 10^(-1/slope) - 1 = 10^(1/3.6) - 1 = 89.6 percent. A slope of -3.32 gives about 100 percent, -3.1 about 110.2 percent and -4.0 about 77.8 percent. Steeper (more negative) slopes mean lower efficiency.

Further reading: Bustin SA et al. The MIQE guidelines. Clin Chem 2009;55:611-622.

3 · PCR and quantitative PCR · hard

A qPCR standard curve follows Ct = -3.3 x log10(copies) + 38. A sample gives Ct 25. How many target copies were in the reaction?

  1. About 87,000 copies
  2. About 870 copies
  3. About 8,700 copies
  4. About 3.9 copies
Answer and working

C. About 8,700 copies

log10(copies) = (38 - 25)/3.3 = 3.939; copies = 10^3.939 = about 8700. Stopping at the logarithm gives 3.9; misplacing the exponent by one gives 870 or 87,000.

4 · Molecular diagnostics · medium

A dog treated with doxycycline for 2 weeks has a blood PCR still positive for Ehrlichia canis, but it is now clinically normal. The best interpretation is that PCR:

  1. Proves that doxycycline treatment has failed and that this Ehrlichia strain is now resistant to tetracyclines
  2. Is always falsely positive after doxycycline
  3. Detects nucleic acid and cannot alone distinguish live organisms from residual DNA or a carrier state
  4. Shows the dog is now immune
Answer and working

C. Detects nucleic acid and cannot alone distinguish live organisms from residual DNA or a carrier state

PCR positivity means target DNA is present, not necessarily viable, replicating organisms or disease. Decisions rest on clinical status, repeat testing after an interval and haematology. A single positive does not prove resistance, and PCR says nothing about immunity.

5 · Animal tissue culture · hard

A vaccine manufacturer finds bovine viral diarrhoea virus RNA in a batch made in bovine cells, though no cytopathic effect was seen. The most probable source is:

  1. Contamination from the operator's skin
  2. Contaminated fetal bovine serum used in the medium
  3. Mutation of the vaccine virus into a pestivirus
  4. Trypsin of porcine origin
Answer and working

B. Contaminated fetal bovine serum used in the medium

Pestiviruses, including non-cytopathic BVDV, are recognised contaminants of fetal bovine serum and hence of cell lines and biologicals; being non-cytopathic, they cause no visible change. Serum is therefore tested or treated (for example by irradiation), and cell banks are screened. Porcine trypsin is a separate risk, mainly porcine parvovirus.

Further reading: Freshney RI. Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications, 7th ed.

6 · Stem cells · medium

In horses, the most established clinical use of autologous mesenchymal stromal cells has been in:

  1. Strangles
  2. Laminitis caused by carbohydrate overload as a first-line treatment
  3. Superficial digital flexor tendon injuries
  4. Equine infectious anaemia
Answer and working

C. Superficial digital flexor tendon injuries

Bone-marrow or adipose-derived cells injected into core lesions of the superficial digital flexor tendon are the best-known equine application, though the controlled-trial evidence is still limited. They are not a treatment for viral or bacterial infections.

7 · Stem cells · hard

Current evidence suggests that much of the therapeutic effect of injected mesenchymal stromal cells comes from:

  1. Secreted paracrine and immunomodulatory factors rather than long-term engraftment
  2. Permanent differentiation of the injected cells into all of the injured tissue types they reach
  3. Fusion with host neurons
  4. Direct killing of bacteria by phagocytosis
Answer and working

A. Secreted paracrine and immunomodulatory factors rather than long-term engraftment

Tracking studies show that few injected MSCs persist; their benefit is attributed mainly to secreted cytokines, growth factors and extracellular vesicles that modulate inflammation and repair.

8 · Embryo transfer and in-vitro fertilisation · hard

Why do properly washed, zona-intact in-vivo-derived bovine embryos carry a low risk of transmitting many infectious diseases?

  1. Embryos generally cannot be infected by any pathogen
  2. The intact zona pellucida plus IETS washing (with trypsin for some agents) removes or excludes most pathogens
  3. Recipients are always immune to all pathogens
  4. Embryos are routinely treated with broad-spectrum antiviral drugs (and antibiotics) before transfer to recipients
Answer and working

B. The intact zona pellucida plus IETS washing (with trypsin for some agents) removes or excludes most pathogens

The zona pellucida acts as a barrier, and sequential washes, with trypsin for certain viruses, remove adherent agents. Some pathogens stick to the zona, so washing protocols, donor testing and certification are all needed; in-vitro embryos have a less protective zona surface.

Further reading: Stringfellow DA, Givens MD (eds). Manual of the International Embryo Transfer Society, 4th ed.

9 · Hybridoma technology and monoclonal antibodies · hard

A licensed monoclonal antibody for dogs with osteoarthritis pain works by neutralising:

  1. Cyclo-oxygenase-2 enzyme
  2. Nerve growth factor
  3. Tumour necrosis factor-alpha
  4. Interleukin-31 (itch cytokine)
Answer and working

B. Nerve growth factor

Anti-NGF antibodies (caninised for dogs, felinised for cats) reduce osteoarthritis pain signalling. The anti-IL-31 antibody is for pruritus in atopic dermatitis; COX-2 is inhibited by small-molecule NSAIDs, not antibodies. Availability varies by country.

10 · Transgenic animals · hard

Genome-edited polled dairy cattle were later found by a regulatory analysis to carry unintended bacterial plasmid DNA at the edited site. The main lesson for regulators and developers is that:

  1. Editing can never introduce foreign DNA, so the plasmid must have come from contamination during sequencing
  2. All edited animals must be cloned
  3. Polledness is a harmful trait
  4. Edited animals need genome-wide or long-read checks for unintended insertions at the target site
Answer and working

D. Edited animals need genome-wide or long-read checks for unintended insertions at the target site

Checking only that the intended allele is present missed the integrated plasmid backbone including antibiotic-resistance genes. Thorough sequencing of the edited locus and genome is now expected.

Ten here, 41 in the app. The Laisha app has every practice question we have written to ICAR AICE-JRF/SRF in this subject, marked as you go, with timed papers, a jump-to-unanswered list and a certificate when you pass at 70 per cent.

Free for ten days, then one subscription of US$10 a month. We would rather say so here than have you find it later.

Practise the full set in Laisha →

Read the subject

Veterinary and Animal BiotechnologyThe full study manual, free ICAR AICE-JRF/SRFFormat, sections and how it has changed

More ICAR AICE-JRF/SRF practice

Systematic Veterinary VirologyRegulatory and State Veterinary Medicine & International TradeMilk & Meat Hygiene, Food Safety & Public HealthVeterinary Epidemiology & ZoonosesPreventive Veterinary Medicine I: Bacterial, Fungal, Rickettsial and Mycoplasmal DiseasesLivestock Economics, Marketing & Business ManagementLaboratory Animal Science & MedicineVeterinary Histology, Embryology & Developmental AnatomyVeterinary Immunology & SerologySystematic Veterinary Bacteriology & MycologyGeneral Veterinary PathologyEnvironment & Environmental HygieneAnimal Welfare, Ethics & Veterinary JurisprudenceVeterinary Research Methodology & Evidence-Based Veterinary MedicineLivestock & Poultry BreedingWildlife, Zoo Animal & Conservation MedicineFodder Production & Grassland ManagementClinical, Diagnostic & Immuno-ParasitologyLivestock Production Management II: Monogastric and Laboratory AnimalsGeneral & Systemic Veterinary PharmacologyPrinciples of Animal Nutrition & Feed TechnologyLivestock Production Management III: Species of Regional InterestApplied Animal Nutrition II: Non-ruminants, Poultry, Laboratory and Companion AnimalsVeterinary Clinical Practice (Veterinary Clinical Complex)

Veterinary and Animal Biotechnology for other exams

ASRB NET and ARS / SMS / STO · IndiaICAR AIEEA · India

Ask Laisha about this

Opens Laisha's chat with your question ready to send. Sign in or start free.